Literature DB >> 34155414

Integrated genomic, epidemiologic investigation of Candida auris skin colonization in a skilled nursing facility.

Julia A Segre1, Mary K Hayden2, Diana M Proctor3, Thelma Dangana4, D Joseph Sexton5, Christine Fukuda4, Rachel D Yelin4, Mary Stanley4, Pamela B Bell4, Sangeetha Baskaran4, Clay Deming3, Qiong Chen3, Sean Conlan3, Morgan Park6, Rory M Welsh5, Snigdha Vallabhaneni5,7, Tom Chiller5, Kaitlin Forsberg5, Stephanie R Black8, Massimo Pacilli8, Heidi H Kong9, Michael Y Lin4, Michael E Schoeny10, Anastasia P Litvintseva5.   

Abstract

Candida auris is a fungal pathogen of high concern due to its ability to cause healthcare-associated infections and outbreaks, its resistance to antimicrobials and disinfectants and its persistence on human skin and in the inanimate environment. To inform surveillance and future mitigation strategies, we defined the extent of skin colonization and explored the microbiome associated with C. auris colonization. We collected swab specimens and clinical data at three times points between January and April 2019 from 57 residents (up to ten body sites each) of a ventilator-capable skilled nursing facility with endemic C. auris and routine chlorhexidine gluconate (CHG) bathing. Integrating microbial-genomic and epidemiologic data revealed occult C. auris colonization of multiple body sites not targeted commonly for screening. High concentrations of CHG were associated with suppression of C. auris growth but not with deleterious perturbation of commensal microbes. Modeling human mycobiome dynamics provided insight into underlying alterations to the skin fungal community as a possible modifiable risk factor for acquisition and persistence of C. auris. Failure to detect the extensive, disparate niches of C. auris colonization may reduce the effectiveness of infection-prevention measures that target colonized residents, highlighting the importance of universal strategies to reduce C. auris transmission.
© 2021. This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply.

Entities:  

Mesh:

Year:  2021        PMID: 34155414      PMCID: PMC9396956          DOI: 10.1038/s41591-021-01383-w

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   87.241


  15 in total

1.  Candida auris Pan-Drug-Resistant to Four Classes of Antifungal Agents.

Authors:  Samantha E Jacobs; Jonathan L Jacobs; Emily K Dennis; Sarah Taimur; Meenakshi Rana; Dhruv Patel; Melissa Gitman; Gopi Patel; Sarah Schaefer; Kishore Iyer; Jang Moon; Victoria Adams; Polina Lerner; Thomas J Walsh; YanChun Zhu; Mohammed Rokebul Anower; Mayuri M Vaidya; Sudha Chaturvedi; Vishnu Chaturvedi
Journal:  Antimicrob Agents Chemother       Date:  2022-06-30       Impact factor: 5.938

2.  A pan-cancer mycobiome analysis reveals fungal involvement in gastrointestinal and lung tumors.

Authors:  Anders B Dohlman; Jared Klug; Marissa Mesko; Iris H Gao; Steven M Lipkin; Xiling Shen; Iliyan D Iliev
Journal:  Cell       Date:  2022-09-29       Impact factor: 66.850

3.  Transcriptional Response of Candida auris to the Mrr1 Inducers Methylglyoxal and Benomyl.

Authors:  Amy R Biermann; Deborah A Hogan
Journal:  mSphere       Date:  2022-04-27       Impact factor: 5.029

4.  Population genomic analyses reveal evidence for limited recombination in the superbug Candida auris in nature.

Authors:  Yue Wang; Jianping Xu
Journal:  Comput Struct Biotechnol J       Date:  2022-06-16       Impact factor: 6.155

Review 5.  Tools for Detecting a "Superbug": Updates on Candida auris Testing.

Authors:  Shawn R Lockhart; Meghan M Lyman; D Joseph Sexton
Journal:  J Clin Microbiol       Date:  2022-01-05       Impact factor: 11.677

6.  Depletion of the Microbiota Has a Modest but Important Impact on the Fungal Burden of the Heart and Lungs during Early Systemic Candida auris Infection in Neutropenic Mice.

Authors:  Amber M Pichowicz; Steven R Torres; Fernando J Torres-Velez; Adina D Longyear; Navjot Singh; Erica Lasek-Nesselquist; Magdia De Jesus
Journal:  Microorganisms       Date:  2022-02-01

7.  Bioassay-Guided Interpretation of Antimicrobial Compounds in Kumu, a TCM Preparation From Picrasma quassioides' Stem via UHPLC-Orbitrap-Ion Trap Mass Spectrometry Combined With Fragmentation and Retention Time Calculation.

Authors:  Haibo Hu; Changling Hu; Jinnian Peng; Alokesh Kumar Ghosh; Ajmal Khan; Dan Sun; Walter Luyten
Journal:  Front Pharmacol       Date:  2021-10-27       Impact factor: 5.988

8.  Antifungal-Loaded Calcium Sulfate Beads as a Potential Therapeutic in Combating Candida auris.

Authors:  Mark C Butcher; Jason L Brown; Donald Hansom; Rebecca Wilson-Van Os; Craig Delury; Phillip A Laycock; Gordon Ramage
Journal:  Antimicrob Agents Chemother       Date:  2021-10-25       Impact factor: 5.191

9.  Novel Chromogenic Medium CHROMagarTM Candida Plus for Detection of Candida auris and Other Candida Species from Surveillance and Environmental Samples: A Multicenter Study.

Authors:  Juan Vicente Mulet Bayona; Carme Salvador García; Nuria Tormo Palop; Amparo Valentín Martín; Carmelo González Padrón; Javier Colomina Rodríguez; Javier Pemán; Concepción Gimeno Cardona
Journal:  J Fungi (Basel)       Date:  2022-03-09

10.  Skin Metagenomic Sequence Analysis of Early Candida auris Outbreaks in U.S. Nursing Homes.

Authors:  Xin Huang; Rory M Welsh; Clay Deming; Diana M Proctor; Pamela J Thomas; Gabrielle M Gussin; Susan S Huang; Heidi H Kong; Meghan L Bentz; Snigdha Vallabhaneni; Tom Chiller; Brendan R Jackson; Kaitlin Forsberg; Sean Conlan; Anastasia P Litvintseva; Julia A Segre
Journal:  mSphere       Date:  2021-08-04       Impact factor: 4.389

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.